{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:50:42Z","timestamp":1783032642457,"version":"3.54.6"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5KL2TR001419-02"],"award-info":[{"award-number":["5KL2TR001419-02"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["Solomon18YO"],"award-info":[{"award-number":["Solomon18YO"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0844-4","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T12:02:49Z","timestamp":1556193769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Employment of an algorithm of care including chest physiotherapy results in reduced hospitalizations and stability of lung function in bronchiectasis"],"prefix":"10.1186","volume":"19","author":[{"given":"Jordan","family":"Powner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nesmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denay P.","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent","family":"Bermingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"issue":"5","key":"844_CR1","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","volume":"151","author":"TR Aksamit","year":"2017","unstructured":"Aksamit TR, O'Donnell AE, Barker A, et al. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017;151(5):982\u201392.","journal-title":"Chest."},{"issue":"6","key":"844_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, et al. Non\u2013cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"844_CR3","first-page":"1420","volume":"127","author":"P Scheinberg","year":"2015","unstructured":"Scheinberg P, Shore E. A pilot study of the safety and efficacy of tobramycin solution for inhalation in patients with severe bronchiectasis. Chest. 2015;127(4):1420\u20136.","journal-title":"Chest."},{"issue":"8","key":"844_CR4","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","volume":"189","author":"CS Haworth","year":"2014","unstructured":"Haworth CS, Foweraker JE, Wilkinson P, et al. Inhaled Colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection. Am J Respir Crit Care Med. 2014;189(8):975\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"844_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.2013.2290","volume":"309","author":"DJ Serisier","year":"2013","unstructured":"Serisier DJ, Martin ML, McGuckin MA, et al. Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non\u2013cystic fibrosis bronchiectasis the BLESS randomized controlled trial. JAMA. 2013;309(12):1260\u20137.","journal-title":"JAMA."},{"issue":"12","key":"844_CR6","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1001\/jama.2013.1937","volume":"309","author":"J Altenburg","year":"2013","unstructured":"Altenburg J, de Graaff CS, Stienstra Y, et al. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non\u2013cystic fibrosis bronchiectasis the BAT randomized controlled trial. JAMA. 2013;309(12):1251\u20139.","journal-title":"JAMA."},{"key":"844_CR7","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","volume":"197","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Aliberti S, Filonenko A, et al. Characterisation of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis. Am J Respir Crit Care Med. 2018;197:1410\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"844_CR8","doi-asserted-by":"crossref","unstructured":"Mogayzel, Jr PJ., Naureckas ET, Robinson KA, et al. Cystic fibrosis pulmonary guidelines chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2013;187(7): 680\u2013689.","DOI":"10.1164\/rccm.201207-1160OE"},{"issue":"4","key":"844_CR9","first-page":"522","volume":"54","author":"PA Flume","year":"2009","unstructured":"Flume PA, Robinson KA, O'Sullivan BP, Finder JD, et al. Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009;54(4):522\u201337.","journal-title":"Respir Care"},{"issue":"9","key":"844_CR10","first-page":"1210","volume":"52","author":"JB Fink","year":"2007","unstructured":"Fink JB. Forced expiratory technique, directed cough, and autogenic drainage. Respir Care. 2007;52(9):1210\u201323.","journal-title":"Respir Care"},{"issue":"5","key":"844_CR11","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","volume":"113","author":"AE O'Donnell","year":"1997","unstructured":"O'Donnell AE, Barker IJS, et al. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. Chest. 1997;113(5):1329\u201334.","journal-title":"Chest."},{"issue":"2","key":"844_CR12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1164\/ajrccm.154.2.8756815","volume":"154","author":"PJ Wills","year":"1996","unstructured":"Wills PJ, Wodehouse T, Corkery K, et al. Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med. 1996;154(2 Pt 1):413\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"844_CR13","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1056\/NEJMoa043891","volume":"354","author":"SH Donaldson","year":"2006","unstructured":"Donaldson SH, Bennett WD, Zeman KL, et al. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354(3):241\u201325.","journal-title":"N Engl J Med"},{"issue":"3","key":"844_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa043900","volume":"354","author":"MR Elkins","year":"2006","unstructured":"Elkins MR, Robinson M, Rose BR, et al. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis. N Engl J Med. 2006;354(3):229\u201340.","journal-title":"N Engl J Med"},{"issue":"1","key":"844_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.rmed.2004.05.006","volume":"99","author":"F Kellett","year":"2005","unstructured":"Kellett F, Redfern J, Niven RM. Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasis. Respir Med. 2005;99(1):27\u201331.","journal-title":"Respir Med"},{"issue":"12","key":"844_CR16","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.rmed.2011.07.019","volume":"105","author":"F Kellett","year":"2011","unstructured":"Kellett F, Robert NM. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis. Respir Med. 2011;105(12):1831\u20135.","journal-title":"Respir Med"},{"issue":"5","key":"844_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.rmed.2011.12.021","volume":"106","author":"CHH Nicolson","year":"2012","unstructured":"Nicolson CHH, Stirling RG, Borg BM, et al. The long-term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis. Respir Med. 2012;106(5):661\u20137.","journal-title":"Respir Med"},{"key":"844_CR18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/thoraxjnl-2012-202915","volume":"68","author":"MP McIlwaine","year":"2013","unstructured":"McIlwaine MP, Alarie N, Davidson GF, et al. Long-term multicentre randomised controlled study of high frequency Chest Wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax. 2013;68:746\u201351.","journal-title":"Thorax."},{"key":"844_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2466-13-21","volume":"13","author":"A Nicolini","year":"2013","unstructured":"Nicolini A, Cardini F, Landucci N, et al. Effectiveness of treatment with high-frequency Chest Wall oscillation in patients with bronchiectasis. BMC Pulmonary Medicine. 2013;13:21.","journal-title":"BMC Pulmonary Medicine"},{"issue":"6","key":"844_CR20","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00051-2017","volume":"49","author":"AT Hill","year":"2017","unstructured":"Hill AT, Haworth CS, Aliberti S, et al. Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research. Eur Respir J. 2017;49(6):1700051.","journal-title":"Eur Respir J"},{"issue":"6","key":"844_CR21","volume":"55","author":"RR Kempainen","year":"2010","unstructured":"Kempainen RR, Milla C, Dunitz J, Savik K, Hazelwood A, Williams C, et al. Comparison of settings used for high-frequency chest wall compression in cystic fibrosis. Respir Care. 2010;55(6):695701.","journal-title":"Respir Care"},{"key":"844_CR22","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","volume":"196","author":"BH Culver","year":"2017","unstructured":"Culver BH, Graham BL, Coates AL, et al. ATS Committee on proficiency standards for pulmonary function laboratories. Recommendations for a standardized pulmonary function report: an official American Thoracic Society technical statement. Am J Respir Crit Care Med. 2017;196:1463\u201372.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"844_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.chest.2017.07.037","volume":"152","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Restrepo MI. Bronchiectasis management the state of the union. Chest. 2017;152(6):1097\u20139.","journal-title":"Chest."},{"key":"844_CR24","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1164\/rccm.201505-0926UP","volume":"192","author":"B Amalakuhan","year":"2015","unstructured":"Amalakuhan B, Maselli DJ, Martinez-Garcia MA. Update in bronchiectasis 2014. Am J Respir Crit Care Med. 2015;192:1155\u201361.","journal-title":"Am J Respir Crit Care Med"},{"key":"844_CR25","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/thx.2010.142778","volume":"65","author":"MC Pasteur","year":"2010","unstructured":"Pasteur MC, Bilton D, Hill AT, et al. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65:577.","journal-title":"Thorax."},{"key":"844_CR26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017","volume":"50","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50:1700629.","journal-title":"Eur Respir J"},{"key":"844_CR27","doi-asserted-by":"crossref","unstructured":"Chang AB, Bell SC, Torzillo PJ, et al. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Medical Journal of Australia. 201;202(3):130.","DOI":"10.5694\/mjac14.00287"},{"key":"844_CR28","doi-asserted-by":"crossref","unstructured":"Welsh EJ, Evans DJ, Fowler SJ, et al. Interventions for bronchiectasis: an overview of Cochrane systemic reviews. Cochrane Database of systemic Reviews. 2015;7.","DOI":"10.1002\/14651858.CD010337.pub2"},{"issue":"5","key":"844_CR29","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","volume":"189","author":"JD Chalmers","year":"2014","unstructured":"Chalmers JD, Goeminne P, Aliberti S, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576\u201385.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0844-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0844-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0844-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T11:22:27Z","timestamp":1589455347000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0844-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["844"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0844-4","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"6 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and informed consent was waived by the University of Alabama at Birmingham IRB committee due to the study being standard of care. The IRB protocol number is IRB-150922010.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"82"}}